1. De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC; Italian Working Group on Endocrine Complications in Non-Endocrine Diseases. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab 2006, 19: 471–80.
2. Constantoulakis M, Panagopoulos G, Augoustaki O. Stature and longitudinal growth in thalassemia major. A study of 229 Greek patients. Clin Pediatr (Phila) 1975, 14: 355–7/362-8.
3. Cavallo L, De Mattia D, Giobbe T, et al. Growth in homozygous β-thalassemia patients. In: Cavallo L, Job JC, New MI, eds. Growth Disorders: the State of the art. Serono Symposia No. 81. Rome: Raven Press. 1991, 47–54.
4. Garcia-Mayor RV, Andrade Olivie A, Fernández Catalina P, Castro M, Rego Iraeta A, Reparaz A. Linear growth in thalassemic children treated with intensive chelation therapy. A longitudinal study. Horm Res 1993, 40: 189–93.
5. Rodda CP, Reid ED, Johnson S, Doery J, Matthews R, Bowden DK. Short stature in homozygous β-thalassemia is due to disproportionate truncal shortening. Clin Endocrinol (Oxf) 1995, 42: 587–92.